The global psoriasis market is estimated to grow significantly during the forecast period. Psoriasis is a genetic condition in which skin cells build up and form scales and itchy, dry patches. It is also considered an immune system problem, that causes rashes on the skin. The primary treatment for psoriasis is medications, that aim to eliminate scales and prevent skin cells from growing rapidly. Topical ointments, light therapy, and medication can also offer relief in psoriasis itchiness.
Get Free Sample link @ https://www.omrglobal.com/request-sample/psoriasis-drugs-market
The primary factors that drive the growth of the market include the increased incidences of psoriasis cases across the globe. As per the National Psoriasis Foundation in 2020, more than 8 million Americans suffer from psoriasis. According to the World Psoriasis Day consortium, globally 125 million people that is more than 3% of the total population suffers from psoriasis. Further, the increasing disease burden and demand for psoriasis medicines along with the rapid R&D activities in psoriasis research and pipeline drugs are some of the factors supporting the growth of the market.
A full report of Global Psoriasis Drugs Market available @ https://www.omrglobal.com/industry-reports/psoriasis-drugs-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Psoriasis Drugs Market by Drug Class
- Tumor Necrosis Factor (TNF) Inhibitors
- Interleukin Inhibitors
- Vitamin D Analogs
- Others
Global Psoriasis Drugs Market by Route of Administration
- Oral
- Parenteral
- Topical
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- AbbVie, Inc.
- Amgen Inc.
- AstraZeneca Plc
- Bausch Health Companies Inc.
- Biogen, Inc.
- Boehringer Ingelheim International GmbH
- Celltrion Healthcare Co. Ltd.
- Reddy’s Laboratories Ltd.
- Eli Lilly and Co.
- Johnson & Johnson Services Inc.
- LEO Pharma A/S
- Merck & Co. Inc.
- Novartis International AG
- Pfizer, Inc.
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Co. Ltd.
- UCB SA
The Report Covers
- Market value data analysis of 2018 and forecast to 2025.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Psoriasis Drugs market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/psoriasis-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
